We found that the PD + Cyproheptadine group was able to significantly decrease the levels of P-P65, P-P38, P-ERK and P-JNK compared to the PD + DMSO group (Figure 7G, P < 0.01). The gene discussed is MAPK8; the disease is Parkinson disease.